NASDAQ:PSNLPersonalis Stock Price, Forecast & News

Personalis' stock was trading at $6.02 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, PSNL shares have increased by 136.0% and is now trading at $14.21. View which stocks have been most impacted by Coronavirus.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Personalis in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Personalis.

Personalis is scheduled to release its next quarterly earnings announcement on Tuesday, August 11th 2020. View our earnings forecast for Personalis.

Personalis (NASDAQ:PSNL) posted its quarterly earnings data on Thursday, May, 7th. The company reported ($0.29) EPS for the quarter, missing the Zacks' consensus estimate of ($0.26) by $0.03. The business earned $19.16 million during the quarter, compared to the consensus estimate of $16.80 million. Personalis had a negative net margin of 40.60% and a negative return on equity of 26.28%. View Personalis' earnings history.

5 analysts have issued 1-year target prices for Personalis' stock. Their forecasts range from $14.00 to $29.00. On average, they expect Personalis' share price to reach $22.25 in the next year. This suggests a possible upside of 56.6% from the stock's current price. View analysts' price targets for Personalis.

News stories about PSNL stock have been trending negative on Sunday, according to InfoTrie Sentiment. The research firm ranks the sentiment of press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Personalis earned a daily sentiment score of -2.2 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 5.0 out of 10, meaning that recent press coverage is somewhat likely to have an effect on the company's share price in the next several days. View the latest news about Personalis.

Personalis saw a decline in short interest in June. As of June 15th, there was short interest totaling 895,500 shares, a decline of 15.5% from the May 31st total of 1,060,000 shares. Based on an average trading volume of 365,200 shares, the short-interest ratio is presently 2.5 days. Approximately 5.7% of the shares of the stock are short sold. View Personalis' Current Options Chain.

Some companies that are related to Personalis include CareDx (CDNA), Veracyte (VCYT), RadNet (RDNT), Castle Biosciences (CSTL), Centogene (CNTG), Fulgent Genetics (FLGT), DermTech (DMTK), Enzo Biochem (ENZ), Biocept (BIOC), Celcuity (CELC), Anpac Bio-Medical Science (ANPC), Miragen Therapeutics (MGEN), Psychemedics (PMD), OpGen (OPGN) and Avant Diagnostics (AVDX). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Personalis investors own include Editas Medicine (EDIT), Canopy Growth (CGC), Ford Motor (F), Flexion Therapeutics (FLXN), Proteostasis Therapeutics (PTI), Enphase Energy (ENPH), Energy Transfer LP Unit (ET), Inovio Pharmaceuticals (INO), NIO (NIO) and Viking Therapeutics (VKTX).

(PSNL) raised $100 million in an initial public offering (IPO) on Thursday, June 20th 2019. The company issued 6,700,000 shares at a price of $14.00-$16.00 per share. Morgan Stanley, BofA Merrill Lynch and Cowen and Company served as the underwriters for the IPO and Oppenheimer was co-manager.

Personalis trades on the NASDAQ under the ticker symbol "PSNL."

Shares of PSNL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of PSNL stock can currently be purchased for approximately $14.21.

Personalis has a market capitalization of $450.60 million and generates $65.21 million in revenue each year. The company earns $-25,080,000.00 in net income (profit) each year or ($1.39) on an earnings per share basis. Personalis employs 181 workers across the globe.

The official website for Personalis is www.personalis.com.

Personalis' mailing address is 1330 O`BRIEN DRIVE, MENLO PARK CA, 94025. The company can be reached via phone at 650-752-1300 or via email at [email protected]